Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features.

Gibson SE, Swerdlow SH, Felgar RE.

Hum Pathol. 2011 May;42(5):679-87. doi: 10.1016/j.humpath.2010.07.023. Epub 2011 Feb 2.

2.

Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.

Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH.

Blood. 1997 Jun 15;89(12):4501-13. Review.

3.

Intra-tumoral cytolytic cells: pattern of distribution in B-cell non Hodgkin s lymphoma.

Perambakam S, Naresh K, Nerurkar A, Nadkarni J.

Pathol Oncol Res. 2000;6(2):114-7.

4.

T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.

Coupland SE, Foss HD, Assaf C, Auw-Haedrich C, Anastassiou G, Anagnostopoulos I, Hummel M, Karesh JW, Lee WR, Stein H.

Ophthalmology. 1999 Nov;106(11):2109-20.

PMID:
10571346
5.

CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.

Almasri NM, Iturraspe JA, Braylan RC.

Arch Pathol Lab Med. 1998 Jun;122(6):539-44.

PMID:
9625422
6.

Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.

Aguilar P, Mathieu CP, Clerc G, Ethevenot G, Fajraoui M, Mattei S, Faure GC, Bene MC.

J Heart Lung Transplant. 2006 Feb;25(2):200-5. Epub 2006 Jan 6.

PMID:
16446221
7.

Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.

Admirand JH, Rassidakis GZ, Abruzzo LV, Valbuena JR, Jones D, Medeiros LJ.

Mod Pathol. 2004 Aug;17(8):954-61.

8.

Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.

Jiang NG, Jin YM, Niu Q, Zeng TT, Su J, Zhu HL.

Ann Hematol. 2013 Jan;92(1):89-96. doi: 10.1007/s00277-012-1574-3. Epub 2012 Sep 20.

PMID:
22992980
9.

[Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].

Xiao C, Su ZL, Wu QL, Gao HY, Fang JC, Xia ZJ, Guan ZZ.

Zhonghua Bing Li Xue Za Zhi. 2005 Jan;34(1):22-7. Chinese.

PMID:
15796877
10.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
11.

Diffuse large B cell lymphoma expressing the natural killer cell marker CD56.

Sekita T, Tamaru JI, Isobe K, Harigaya K, Masuoka S, Katayama T, Kobayashi M, Mikata A.

Pathol Int. 1999 Aug;49(8):752-8.

PMID:
10504545
12.

[Aggressive lymphomas: a convenient concept or an anatomo-pathological reality?].

Pileri SA, Fraternali-Orcioni G, Ascani S, Piccioli M, Poggi S, Piccaluga PP, Leoncini L, Falini B.

Pathologica. 2000 Jun;92(3):145-61. Review. Italian. No abstract available.

PMID:
10902425
13.

Natural killer (NK) cell leukaemia in a patient with a B cell non-Hodgkin's lymphoma.

Dekoninck A, Cartuyvels R, Magerman K, Peeters V, Mewis A, Wuyts B, Delva A, Vanstraelen D, Rummens JL.

Clin Lab Haematol. 2000 Apr;22(2):115-7.

PMID:
10792403
14.

Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas.

Kaleem Z, White G, Zutter MM.

Am J Clin Pathol. 2001 Mar;115(3):396-403.

PMID:
11242796
15.

CD3+/CD16+CD56+ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma.

Hus I, Starosławska E, Bojarska-Junak A, Dobrzyńska-Rutkowska A, Surdacka A, Wdowiak P, Wasiak M, Kusz M, Twardosz A, Dmoszyńska A, Roliński J.

Folia Histochem Cytobiol. 2011;49(1):183-7.

17.

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.

Boudová L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S, Diehl V, Müller-Hermelink HK, Rüdiger T.

Blood. 2003 Nov 15;102(10):3753-8. Epub 2003 Jul 24.

18.
19.

Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.

Massone C, Chott A, Metze D, Kerl K, Citarella L, Vale E, Kerl H, Cerroni L.

Am J Surg Pathol. 2004 Jun;28(6):719-35.

PMID:
15166664
20.

[T-cell/histiocyte-rich B-cell lymphoma: histology, immunophenotype and differential diagnosis].

Liu YH, Zhuang HG, Lin HL, Wu QL, Luo DL, Luo XL.

Zhonghua Bing Li Xue Za Zhi. 2005 Dec;34(12):771-5. Chinese.

PMID:
16545182

Supplemental Content

Support Center